Iron poisoning: A literature-based review of epidemiology, diagnosis, and management

Pediatric Emergency Care

Volumn 27, Issue 10, 2011, Pages 978-985

  Chang, Todd Pou Yen ^a   Rangan, Cyrus ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

chelation; deferoxamine; ferrous sulfate; iron ingestion; iron overdose; iron poisoning

Indexed keywords

BICARBONATE; BISPHOSPHONIC ACID DERIVATIVE; DEFEROXAMINE; EDETATE CALCIUM; FERROUS FUMARATE; FERROUS SULFATE; GLUCOSE; IRON; MAGNESIUM HYDROXIDE; PHOSPHATE;

ADULT RESPIRATORY DISTRESS SYNDROME; CHELATION THERAPY; CHILDHOOD DISEASE; CLINICAL PRACTICE; DRUG FORMULATION; DRUG PACKAGING; ENDOSCOPY; GLUCOSE BLOOD LEVEL; HEMOFILTRATION; HUMAN; HYPOTENSION; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON OVERLOAD; KIDNEY FAILURE; LEUKOCYTE COUNT; MEDICAL LITERATURE; NONHUMAN; PATHOPHYSIOLOGY; PLASMAPHERESIS; REVIEW; RISK ASSESSMENT; SEPSIS; STOMACH LAVAGE;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; CHILD; DEFEROXAMINE; DRUG PACKAGING; FEMALE; HUMANS; IRON; MAGNESIUM HYDROXIDE; POISONING; PREGNANCY; SIDEROPHORES; THERAPEUTIC IRRIGATION;

EID: 80053933520     PISSN: 07495161     EISSN: 15351815     Source Type: Journal    
DOI: 10.1097/PEC.0b013e3182302604     Document Type: Review

References (87)

1. Madiwale T, Liebelt E. Iron: not a benign therapeutic drug. Curr Opin Pediatr. 2006;18:174-179.
2. Smolinske SC, Kaufman MM. Consumer perception of household hazardous materials. Clin Toxicol. 2007;45:522-525. (Pubitemid 46763675)
3. Litovitz T, Manoguerra A. Comparison of pediatric poisoning hazards. Pediatrics. 1992;89:999-1006.
4. Black J, Zenel JA. Child abuse and intentional iron poisoning presenting as shock and persistent acidosis. Pediatrics. 2003;111:197-199. (Pubitemid 36071053)
5. Bronstein AC, Spyker DA, Cantilena LR, et al. 2008 Annual report of the American Association of Poison Control Centers' national Poison Data System (NPDS): 26th Annual Report. Clin Toxicol. 2009;47:911-1084.
6. Morris CC. Pediatric iron poisonings in the United States. South Med J. 2000;93:352-358. (Pubitemid 30241218)
7. Walton WW. An evaluation of the Poison Prevention Packaging Act. Pediatrics. 1982;69:363-370. (Pubitemid 12171592)
8. McIntire MS, Angle CR, Grush ML. How effective is safety packaging? Clin Toxicol. 1976;9:419-425.
9. Wiseman HM, Guest K, Murray VSG, et al. Accidental poisoning in childhoodVa multicenter survey, 2: the role of packaging in accidents involving medications. Hum Toxicol. 1987;6:303-314. (Pubitemid 17140383)
10. Tenenbein M. Unit-Dose packaging of iron supplements and reduction of iron poisoning in young children. Arch Pediatr Adolesc Med. 2005;159:557-560. (Pubitemid 40973478)
11. Food and Drug Administration, HHS. Iron-containing supplements and drugs; label warning statements and unit-dose packaging requirements; removal of regulations for unit-dose packaging requirements for dietary supplements and drugs. Final rule; removal of regulatory provisions in response to court order. Fed Regist. 2003;68:59714-59715.
12. Juurlink DN, Tenenbein M, Koren G, et al. Iron poisoning in young children: association with the birth of a sibling. CMAJ. 2003;168:1539-1542. (Pubitemid 36741191)
13. Dean BS, Krenzelok EP. Multiple vitamins and vitamins with iron: accidental poisoning in children. Vet Hum Toxicol. 1988;30:23-25. (Pubitemid 18080041)
14. Turchen SG, Manoguerra AS, et al. Retrospective analysis of ingestions of iron containing products in the United States: are there differences between chewable vitamins and adult preparations? J Emerg Med. 2000;19:255-258.
15. Finkelstein Y, Aks SE, Bentur Y, et al. Universal versus selective iron supplementation for infants and the risk of unintentional poisoning in young children: a comparative study of two populations. Ann Pharmacother. 2007;41:414-419. (Pubitemid 46536031)
16. Singhi SC, Baranwal AK, Jayasharee M. Acute iron poisoning: clinical picture, intensive care needs and outcome. Indian Pediatr. 2003;40:1177-1182. (Pubitemid 38016198)
17. Spiller HA, Wahlen HS, Stephens TL, et al. Multi-center retrospective evaluation of carbonyl iron ingestions. Vet Hum Toxicol. 2002;44:28-29. (Pubitemid 34087778)
18. Manoguerra AS, Erdman AR, Booze LL, et al. American Academy of Clinical Toxicology. Iron ingestion: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol. 2005;43:533-570.
19. Flomenbaum NE, Goldfrank LR, et al, eds. Goldfrank's Toxicologic Emergencies. 8th ed. New York, NY: McGraw-Hill; 2006.
20. Burkhart KK, Kulig KW, Hammond KB, et al. The rise in the total iron-binding capacity after iron overdose. Ann Emerg Med. 1991;20:532-533.
21. Matteuci MJ, Habibe M, Robson K, et al. Effect of oral calcium disodium EDTA on iron absorption in a human model of iron overdose. Clin Toxicol. 2006;44:39-43. (Pubitemid 44121000)
22. Gomez HG, McClafferty HH, Flory D, et al. Prevention of gastrointestinal iron absorption by chelation from an orally administered premixed deferoxamine/charcoal slurry. Ann Emerg Med. 1997;30:587-592. (Pubitemid 27469161)
23. Banner W, Tong TG. Iron poisoning. Pediatr Clin North Am. 1986;33:393-409. (Pubitemid 16075383)
24. Artman M, Olson RD, Boerth RC. Depression of myocardial contractility in acute iron toxicity in rabbits. Toxicol Appl Pharmacol. 1982;66:329-337. (Pubitemid 13180797)
25. Whitten CF, Chen Y, Gibson GW. Studies in acute iron poisoning. II: further observations on desferrioxamine in the treatment of acute experimental iron poisoning. Pediatrics. 1966;38:102-111.
26. Tenenbein M, Israels SJ. Early coagulopathy in sever iron poisoning. J Pediatr. 1988;113:695-697.
27. Tenenbein M. Toxicokinetics and toxicodynamics of iron poisoning. Toxicol Lett. 1998;102-103:653-656. (Pubitemid 29021296)
28. Tenebein M. Hepatotoxicity in acute iron poisoning. Clin Toxicol. 2001;39:721-726.
29. Robertson A, Tenenbein M. Hepatotoxicity in acute iron poisoning. Hum Exp Toxicol. 2005;24:559-562. (Pubitemid 41729637)
30. Daram SR, Hayashi PH. Acute liver failure due to iron overdose in an adult. South Med J. 2005;98:241-244. (Pubitemid 40279766)
31. Tenenbein M. Benefits of parenteral deferoxamine for acute iron poisoning. Clin Toxicol. 1996;34:485-489. (Pubitemid 26338651)
32. Chyka PA, Butler AY. Assessment of acute iron poisoning by laboratory and clinical observations. Am J Emerg Med. 1993;11:99-103. (Pubitemid 23107667)
33. Leikin S, Vossough P, Mochir-Fatemi F. Chelation therapy in acute iron poisoning. J Pediatr. 1967;71:425-430.
34. Mills KC, Curry SC. Acute iron poisoning. Emerg Med Clin North Am. 1994;12:379-413.
35. Tenenbein M, Yatscoff RW. The total iron-binding capacity in iron poisoning: is it useful? Am J Dis Child. 1991;145:437-439.
36. Roberts WL, Smith PT, Martin WJ, et al. Performance characteristics of three serum iron and total iron-binding capacity methods in acute iron overdose. Am J Clin Pathol. 1999;112:657-664. (Pubitemid 30214756)
37. Siff JE, Meldon SW, Tomassoni AJ. Usefulness of the total iron binding capacity in the evaluation and treatment of acute iron overdose. Ann Emerg Med. 1999;33:73-76. (Pubitemid 29028783)
38. Palatnick W, Tenenbein M. Leukocytosis, hyperglycemia, vomiting, and positive x-rays are not indicators of severity of iron overdose in adults. Am J Emerg Med. 1996;14:454-455. (Pubitemid 26272244)
39. Toledano M, Kozer E, Goldstein LH. Hepcidin in acute iron toxicity. Am J Emerg Med. 2009;27:761-764.
40. Czajka PA, Konrad JD, Duffy JP. Iron poisoning: an in vitro comparison of bicarbonate and phosphate lavage solutions. J Pediatr. 1981;98:491-494. (Pubitemid 11106269)
41. Dean BS, Krenzelok EP. In vivo effectiveness of oral complexation agents in the management of iron poisoning. J Toxicol Clin Toxicol. 1987;25:221-230. (Pubitemid 17133514)
42. Dean BS, Oehme FW, Krenzelok EP. A study of iron complexation in a swine model. Vet Hum Toxicol. 1988;30:313-315.
43. Bachrach L, Correa A, Levin R, et al. Iron poisoning complications of hypertonic phosphate lavage therapy. J Pediatr. 1979;94:147-149. (Pubitemid 9036159)
44. Geffner ME, Opas LM. Phosphate poisoning complicating treatment for iron ingestion. Am J Dis Child. 1980;134:509-510. (Pubitemid 10068672)
45. Wallace KL, Curry SC, LoVecchio F, et al. Effect of magnesium hydroxide on iron absorption following simulated mild iron overdose in human subjects. Acad Emerg Med. 1998;5:961-965. (Pubitemid 28463184)
46. Snyder BK, Clark RF. Effect of magnesium hydroxide administration on iron absorption after a supratherapeutic dose of ferrous sulfate in human volunteers: a randomized controlled trial. Ann Emerg Med. 1999;33:400-405. (Pubitemid 29157564)
47. Shepherd G, Klein-Schwartz W, Burstein AH. Efficacy of the cation exchange resin, sodium polystyrene sulfonate, to decrease iron absorption. J Toxicol Clin Toxicol. 2000;38:389-394. (Pubitemid 30491102)
48. Vale JA, Kulig K. American Academy of Clinical Toxicology. Position paper: gastric lavage. J Toxicol Clin Toxicol. 2004;42:933-943.
49. Teece S, Crawford I. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Gastric lavage in iron overdose. Emerg Med J. 2002;19:251-252.
50. Kirschner R, Donovan JW. Comment on "Ingestion of slow-release iron treated with gastric lavage-never say late." Clin Toxicol. 2008;46:89.
51. Goldstein LH, Berkovitch M. Ingestion of slow-release iron treated with gastric lavage-never say late. Clin Toxicol. 2006;44:343. (Pubitemid 43982377)
52. Ly BT, Schneir AB, Clark RF. Effect of whole bowel irrigation on the pharmacokinetics of an acetaminophen formulation and progression of radiopaque markers through the gastrointestinal tract. Ann Emerg Med. 2004;43:189-195. (Pubitemid 38141460)
53. Scharman EJ, Lembersky R, Krenzelok EP. Efficiency of whole bowel with and without metoclopramide pretreatment. Am J Emerg Med. 1994;12:302-305. (Pubitemid 24149401)
54. American Academy of Clinical Toxicology. Position paper: whole bowel irrigation. Clin Toxicol. 2004;42:843-854.
55. Davis GR, Santa Ana CA, Morawski SG, et al. Development of a lavage solution associated with minimal water and electrolyte absorption or secretion. Gastroenterology. 1980;78:991-995. (Pubitemid 10120915)
56. Tenenbein M.Whole bowel irrigation as a gastrointestinal decontamination procedure after acute poisoning. Med Toxicol. 1988;3:77-84. (Pubitemid 18088635)
57. EversonGW, Bertaccini EJ, O'Leary J. Use of whole bowel irrigation in an infant following iron overdose. Am J Emerg Med. 1991;9:366-369.
58. Velez IL, Gracia R, Mills LD, et al. Iron bezoar retained in colon despite 3 days of whole bowel irrigation. Clin Toxicol. 2004;42:653-656. (Pubitemid 39281700)
59. Howland MA. Risks of parenteral deferoxamine for acute iron poisoning. Clin Toxicol. 1996;34:491-497. (Pubitemid 26338652)
60. Novartis. Desferal [package insert]. Available at: http://www.pharma.us. novartis.com/product/pi/pdf/desferal.pdf. Accessed September 15, 2010.
61. Propper RD, Shurin SB, Nathan DG. Reassessment of the use of desferrioxamine B in iron overload. N Engl J Med. 1976;294:1421-1423.
62. Nielsen JB. Influence of desferrioxamine on the renal excretion of iron. Acta Med Scand. 1963;173:499-504.
63. Berland Y, Charhon SA, Olmer M, et al. Predictive value of desferrioxamine infusion test for bone aluminum deposit in hemodialyzed patients. Nephron. 1985;40:433-435. (Pubitemid 15026161)
64. Robotham JL, Lietmen PS. Acute iron poisoning. A review. Am J Dis Child. 1980;134:875-879. (Pubitemid 10059435)
65. Cheney K, Gumbiner C, Benson B, et al. Survival after a severe iron poisoning treated with intermittent infusions of deferoxamine. J Toxicol Clin Toxicol. 1995;33:61-66.
66. Prasannan L, Flynn JT, Levin JE. Acute renal failure following deferoxamine overdose. Pediatr Nephrol. 2003;18:283-285. (Pubitemid 36790057)
67. Clajus C, Becker JU, Stichtenoth DO, et al. Acute kidney injury due to deferoxamine in a renal transplant patient. Nephrol Dial Transplant. 2007;0:1-3.
68. Koren G, Bentur Y, Strong D et al. Acute changes in renal function associated with deferoxamine therapy. Am J Dis Child. 1989;143:1077-1080. (Pubitemid 19218201)
69. Tenenbein M, Kowalski S, Shenko A, et al. Pulmonary toxic effects of continuous desferrioxamine administration in acute iron poisoning. Lancet. 1992;339:699-701.
70. Sckoczynska A, Kwiecinska D, Kielbinski M, et al. Acute iron poisoning in adult female. Hum Exp Toxicol. 2007;26:663-666. (Pubitemid 47583174)
71. Atas B, Caksen H, Tuncer O, et al. Acute respiratory distress syndrome due to overdose desferrioxamine: report of a child. Med J Malaysia. 2005;60:91-93. (Pubitemid 44152150)
72. Ioannides AS, Panisello JM. Acute respiratory distress syndrome in children with acute iron poisoning: the role of intravenous desferrioxamine. Eur J Pediatr. 2000;159:158-159. (Pubitemid 30139940)
73. Anderson KJ, Rivers RPA. Desferrioxamine in acute iron poisoning. Lancet. 1992;339:1602.
74. Adamkiewicz TV, Berkovitch M, Krishnan C, et al. Infection due to Yersinia enterocolitica in a series of patients with beta-thalassemia: incidence and predisposing factors. Clin Infect Dis. 1998;23:1362-1366. (Pubitemid 29242403)
75. Robins-Browne RM, Prpic JK. Effects of iron and desferrioxamine on infections with Yersinia enterocolitica. Infect Immun. 1985;47:774-779. (Pubitemid 15075874)
76. McElhatton PR, Roberts JC, Sullivan FM. The consequences of iron overdose and its treatment. Hum Exp Toxicol. 1991;10:251-259.
77. Tran T, Wax JR, Pilput C, et al. Intentional iron overdose in pregnancyVmanagement and outcome. J EmergMed. 2000;18:225-228. (Pubitemid 30105825)
78. Curry SC, Bond GR, Raschke R, et al. An ovine model of maternal iron poisoning in pregnancy. Ann Emerg Med. 1990;19:632-638. (Pubitemid 20180904)
79. Tran T, Wax JR, Steinfeld JD, et al. Acute intentional iron overdose in pregnancy. Obstet Gynecol. 1998;92:678-680. (Pubitemid 28440790)
80. Jackson TW, Ling LJ, Washington V. The effect of oral deferoxamine on iron absorption in humans. J Toxicol Clin Toxicol. 1995;33:325-329.
81. Berkovitch M, Livne A, Lushkov G, et al. The efficacy of oral deferiprone in acute iron poisoning. Am J Emerg Med. 2000;18:36-40. (Pubitemid 30073193)
82. Yonker J, Banner W, Picchioni A. Absorption characteristics of iron and deferoxamine onto charcoal. Vet Hum Toxicol. 1980;22(suppl):75.
83. Fassos FF, Berkovitch M, Daneman N, et al. Efficacy of deferiprone in the treatment of acute iron intoxication in rats. J Toxicol Clin Toxicol. 1996;34:279-287. (Pubitemid 26199208)
84. Banner W, Vernon DD, Ward RM, et al. Continuous arteriovenous hemofiltration in experimental iron intoxication. Crit Care Med. 1989;17:1187-1190. (Pubitemid 19276544)
85. Ng HW, Tse ML, Lau FL, et al. Endoscopic removal of iron bezoar following acute overdose. Clin Toxicol. 2008;17:1-3.
86. Carlsson M, Cortes D, Jepsen S, et al. Severe iron intoxication treated with exchange transfusion. Arch Dis Child. 2008;93:321-322. (Pubitemid 352025832)
87. Fassos FF, Berkovitch M, Daneman N, et al. The efficacy of diazepam in the treatment of acute iron overload in rats. Can J Physiol Pharmacol. 1998;76:895-899. (Pubitemid 29138104)